Biologists at Stanford University have developed the LYTAC, a new class of drug that might be the future of therapeutics due to its ability to breakdown previously un-accessible proteins on cell walls and its adaptability. Continue reading Breaking Down Instead of Silencing: A Step Forward in a New Class of Drugs
by Garrett Dunlap figures by Shannon McArdel Every ten minutes, another person joins the list of hundreds of thousands waiting for organ transplants. The wait is sometimes years long, despite many of the candidates being in critical condition. But what if the need for transplant waiting lists could be eliminated? Recent advances in a decades-old technology known as chimerism give reason to believe that this … Continue reading The End of the Waitlist: How chimeras could solve the organ transplant problem
by Caitlin Nichols cover image by Rebecca Clements Modern advances in stem cell technology and genetic engineering are bringing the stuff of science fiction into reality, presenting remarkable promise for expanding knowledge and treating disease. However, these developments also arouse ethical concerns that must be considered when deciding if and how to implement them. One striking example of this relationship between biological advancement and bioethics … Continue reading How we talk about science matters: A bioethicist’s view on controversial research and science policy